Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

Rybelsus: Novo Nordisk’s name-brand version of oral semaglutide tablets to help improve blood sugar levels (along with diet ...

An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

The 62-year-old administrative law judge has Type 1 diabetes and needs the medication ... She felt miserable on the low-carb diet she had to switch to and it left a "dull, nasty headache" for ...

The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. The pharmacist told Wright the pharmacy had tried unsuccessfully to get a wholesaler to ship them new ...

Global diabetes rates have doubled over the past 30 years, with many middle- and low-income countries failing to provide ...

Historically, patients diagnosed with type 2 diabetes mellitus have been treated with oral metformin, ideally accompanied by a healthy diet and exercise ... and pharmacy. Sanofi has taken a ...

Adults in their 30s are at risk of developing metabolic-associated fatty liver disease (MAFLD) due to metabolic changes in ...

Today, Sanofi and Breakthrough T1D UK announce a special collaboration with Beano, to mark World Diabetes Day, 14th November ...

A new alliance between Sanofi and Google has been launched to improve care in people with type 1 and type 2 diabetes, the latest in a growing number of tie-ups between pharma and technology companies.

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.